93 related articles for article (PubMed ID: 154093)
1. Cutaneous reaction to labetalol.
Branford WA; Hunter JA; Muir AL
Practitioner; 1978 Nov; 221(1325):765-7. PubMed ID: 154093
[No Abstract] [Full Text] [Related]
2. [Clinical trial of labetalol (Tranedate) in general practice].
Mathisen R; Sveen K
Tidsskr Nor Laegeforen; 1983 Feb; 103(5):541-3. PubMed ID: 6223408
[No Abstract] [Full Text] [Related]
3. [Lichenoid cutaneous eruptions caused by labetalol].
Bertani E; Sala F; Crosti C; Terragni L
G Ital Dermatol Venereol; 1982; 117(4):229-32. PubMed ID: 6227554
[No Abstract] [Full Text] [Related]
4. Cutaneous reactions to labetalol.
Br Med J; 1978 Apr; 1(6118):987. PubMed ID: 147722
[No Abstract] [Full Text] [Related]
5. [Nifedipine, captopril and labetalol--overviews on the pattern of adverse effects].
Lakartidningen; 1985 Jul; 82(28-29):2531-2. PubMed ID: 3160900
[No Abstract] [Full Text] [Related]
6. [Acute hemodynamic effect of labetalol in severe hypertension].
Omvik P; Lund-Johansen P
Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
[No Abstract] [Full Text] [Related]
7. [Labetalol in ambulatory therapy of hypertension].
Zilcher H; Weber H; Glogar D
Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
[No Abstract] [Full Text] [Related]
8. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
[No Abstract] [Full Text] [Related]
9. [Ergometric control in hypertension treatment with labetalol].
Prohaska H; Honetz N
Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661
[No Abstract] [Full Text] [Related]
10. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
[No Abstract] [Full Text] [Related]
11. Left ventricular failure with labetalol.
Frais MA; Bayley TJ
Postgrad Med J; 1979 Sep; 55(646):567-8. PubMed ID: 514938
[TBL] [Abstract][Full Text] [Related]
12. Labetalol for hypertension.
Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
[No Abstract] [Full Text] [Related]
13. Treatment of severe hypertension by repeated bolus injections of labetalol.
Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
[No Abstract] [Full Text] [Related]
14. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
Dent R; Kellaway GS
N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
[TBL] [Abstract][Full Text] [Related]
15. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
Rossi A; Ziacchi V; Lomanto B
Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
[TBL] [Abstract][Full Text] [Related]
16. [Labetalol in resistant hypertension].
Stern N; Teicher A; Rosenthal T
Harefuah; 1981 Aug; 101(3-4):54-6. PubMed ID: 7319385
[No Abstract] [Full Text] [Related]
17. Labetalol for hypertension.
Drug Ther Bull; 1978 Nov; 16(23):89-90. PubMed ID: 699758
[No Abstract] [Full Text] [Related]
18. Labetalol in the treatment of patients with hypertension and renal function impairment.
Bailey RR
Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
[No Abstract] [Full Text] [Related]
19. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
[TBL] [Abstract][Full Text] [Related]
20. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
Cybulska I; Sznajderman M; Brym E; Czerniewska E
Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
